152006-17-2,MFCD03425584
Catalog No.:AA007YNV

152006-17-2 | 2,3-O-Isopropylidene-l-lyxono-1,4-lactone

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$365.00   $255.00
- +
1g
95%
in stock  
$663.00   $464.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA007YNV
Chemical Name:
2,3-O-Isopropylidene-l-lyxono-1,4-lactone
CAS Number:
152006-17-2
Molecular Formula:
C8H12O5
Molecular Weight:
188.1779
MDL Number:
MFCD03425584
SMILES:
OC[C@@H]1OC(=O)[C@H]2[C@@H]1OC(O2)(C)C
Properties
Computed Properties
 
Complexity:
237  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GHENTUNIVERSITY-WO2016/5340,2016,A1Locationinpatent:Page/Pagecolumn149;150

[2]Cermola,Flavio;DeNisco,Mauro;Manfra,Michele;Pedatella,Silvana;Serpico,Luigia[Molecules,2021,vol.26,#9]

[3]Fan,Ao;Jaenicke,Stephan;Chuah,Gaik-Khuan[OrganicandBiomolecularChemistry,2011,vol.9,#22,p.7720-7726]

[4]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2013/158746,2013,A1

[5]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2014/78778,2014,A2

[6]Kim,Jin-Hee;Yu,Jinha;Alexander,Varughese;Choi,JungHee;Song,Jayoung;Lee,HyukWoo;Kim,HeaOk;Choi,Jungwon;Lee,SangKook;Jeong,LakShin[EuropeanJournalofMedicinalChemistry,2014,vol.83,p.208-225]

[7]CurrentPatentAssignee:SANOFI;TranslateBio(in:Sanofi)-WO2014/152513,2014,A1

[8]Vermote,Arno;Brackman,Gilles;Risseeuw,MartijnD.P.;Coenye,Tom;VanCalenbergh,Serge[BioorganicandMedicinalChemistry,2016,vol.24,#19,p.4563-4575]

[9]Ishii,Kazuki;Saito-Tarashima,Noriko;Ota,Masashi;Yamamoto,Seigi;Okamoto,Yasuko;Tanaka,Yoshiyuki;Minakawa,Noriaki[Tetrahedron,2016,vol.72,#41,p.6589-6594]

[10]CurrentPatentAssignee:TAENAMMEDICOS-KR102007282,2019,B1

[11]Choi,Hongseok;Jacobson,KennethA.;Yu,Jinha;Jeong,LakShin[Pharmaceuticals,2021,vol.14,#4]

[12]An,Seungchan;Byun,WoongSub;Jeong,LakShin;Kim,Gibae;Kim,Minjae;Ko,Hyejin;Kwon,Eun-Ji;Kwon,JeeYoun;Lee,HyukWoo;Lee,SangKook;Mashelkar,KarishmaK.;Noh,Minsoo;Sung,Kisu;Tripathi,SushilK.;Yum,YunA.[Pharmaceuticals,2021,vol.14,#12]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:152006-17-2 Molecular Formula|152006-17-2 MDL|152006-17-2 SMILES|152006-17-2 2,3-O-Isopropylidene-l-lyxono-1,4-lactone
Catalog No.: AA007YNV
152006-17-2,MFCD03425584
152006-17-2 | 2,3-O-Isopropylidene-l-lyxono-1,4-lactone
Pack Size: 250mg
Purity: 95%
in stock
$365.00 $255.00
Pack Size: 1g
Purity: 95%
in stock
$663.00 $464.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA007YNV
Chemical Name: 2,3-O-Isopropylidene-l-lyxono-1,4-lactone
CAS Number: 152006-17-2
Molecular Formula: C8H12O5
Molecular Weight: 188.1779
MDL Number: MFCD03425584
SMILES: OC[C@@H]1OC(=O)[C@H]2[C@@H]1OC(O2)(C)C
Properties
Complexity: 237  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 3  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.4  
Downstream Synthesis Route
30725-00-9    152006-17-2 

[1]CurrentPatentAssignee:GHENTUNIVERSITY-WO2016/5340,2016,A1Locationinpatent:Page/Pagecolumn149;150

[2]Cermola,Flavio;DeNisco,Mauro;Manfra,Michele;Pedatella,Silvana;Serpico,Luigia[Molecules,2021,vol.26,#9]

[3]Fan,Ao;Jaenicke,Stephan;Chuah,Gaik-Khuan[OrganicandBiomolecularChemistry,2011,vol.9,#22,p.7720-7726]

[4]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2013/158746,2013,A1

[5]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2014/78778,2014,A2

[6]Kim,Jin-Hee;Yu,Jinha;Alexander,Varughese;Choi,JungHee;Song,Jayoung;Lee,HyukWoo;Kim,HeaOk;Choi,Jungwon;Lee,SangKook;Jeong,LakShin[EuropeanJournalofMedicinalChemistry,2014,vol.83,p.208-225]

[7]CurrentPatentAssignee:SANOFI;TranslateBio(in:Sanofi)-WO2014/152513,2014,A1

[8]Vermote,Arno;Brackman,Gilles;Risseeuw,MartijnD.P.;Coenye,Tom;VanCalenbergh,Serge[BioorganicandMedicinalChemistry,2016,vol.24,#19,p.4563-4575]

[9]Ishii,Kazuki;Saito-Tarashima,Noriko;Ota,Masashi;Yamamoto,Seigi;Okamoto,Yasuko;Tanaka,Yoshiyuki;Minakawa,Noriaki[Tetrahedron,2016,vol.72,#41,p.6589-6594]

[10]CurrentPatentAssignee:TAENAMMEDICOS-KR102007282,2019,B1

[11]Choi,Hongseok;Jacobson,KennethA.;Yu,Jinha;Jeong,LakShin[Pharmaceuticals,2021,vol.14,#4]

[12]An,Seungchan;Byun,WoongSub;Jeong,LakShin;Kim,Gibae;Kim,Minjae;Ko,Hyejin;Kwon,Eun-Ji;Kwon,JeeYoun;Lee,HyukWoo;Lee,SangKook;Mashelkar,KarishmaK.;Noh,Minsoo;Sung,Kisu;Tripathi,SushilK.;Yum,YunA.[Pharmaceuticals,2021,vol.14,#12]

Building Blocks More >
13558-31-1
13558-31-1
Rhodamine 110
AA007ZFD | MFCD00042009
13450-77-6
13450-77-6
2-(4-Chlorobenzamido)acetic acid
AA007ZVK | MFCD00020447
135788-08-8
135788-08-8
2,3-BIS(4-CHLOROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
AA0080C9 | MFCD00060008
1207625-18-0
1207625-18-0
3-Chloro-7h-pyrrolo[2,3-c]pyridazine
AA0080R7 | MFCD17169850
117833-18-8
117833-18-8
Ac-Asp(OtBu)-OH
AA0081C0 | MFCD00236746
111600-85-2
111600-85-2
2-Ethynyl-1,3-thiazole
AA00824K | MFCD13189814
106891-32-1
106891-32-1
Methyl-(2-thiophen-2-yl-ethyl)-amine
AA0082S5 | MFCD04114520
1065074-30-7
1065074-30-7
6-Bromo-8-trifluoromethylquinoline
AA0083H8 | MFCD11504884
107967-88-4
107967-88-4
2-(2-Methoxyphenoxy)acetohydrazide
AA00844N | MFCD00553729
1041434-13-2
1041434-13-2
3,5-Dicarboxyphenylboronic acid, pinacol ester
AA0084SP | MFCD11867793
Submit
© 2017 AA BLOCKS, INC. All rights reserved.